Documentos de Lupe Carolina Espinoza | REDI

Regresar

Mostrando 10 resultados de: 10

Filtros aplicados

Objetivos de Desarrollo Sostenible: "ODS 9: Industria, innovación e infraestructura"

Subtipo de publicación

Publisher

Pharmaceuticals(2)

Pharmaceutics(2)

CNS and Neurological Disorders - Drug Targets(1)

European Journal of Pharmaceutical Sciences(1)

Área temáticas

Farmacología y terapéutica(9)

Enfermedades(5)

Medicina y salud(3)

Cirugía y especialidades médicas afines(1)

Área de conocimiento

Farmacología(7)

Descubrimiento de fármacos(2)

Antibiótico(1)

Ciencia de materiales(1)

Objetivos de Desarrollo Sostenible

ODS 10: Reducción de las desigualdades(10)

ODS 3: Salud y bienestar(10)

Año de Publicación

Origen

Palabras Claves

Pioglitazone(4)

Alzheimer’s disease(3)

NANOEMULSIÓN(3)

Alzheimer's disease(2)

Comparative Study of Donepezil-Loaded Formulations for the Treatment of Alzheimer’s Disease by Nasal Administration

Abstract: Alzheimer’s disease is characterized by a progressive deterioration of neurons resulting in a steady

Palabras claves:

Alzheimer’s disease, Donepezil, gel, intranasal administration

Brito-Llera A., Calpena A.C., Diana Guaya, Halbaut L., Lupe Carolina Espinoza, Mallandrich M., Perotti R.M., Sosa L.

Comparative study of Ex Vivo transmucosal permeation of pioglitazone nanoparticles for the treatment of Alzheimer's disease

Abstract: Pioglitazone has been reported in the literature to have a substantial role in the improvement of ov

Palabras claves:

Alzheimer's disease, Nanoparticles, Pioglitazone, PLGA-PEG, Transmucosal permeations

Calpena A.C., Espina M., García M.L., Halbaut L., Lupe Carolina Espinoza, Silva-Abreu M.

Apremilast microemulsion as topical therapy for local inflammation: Design, characterization and efficacy evaluation

Abstract: Apremilast (APR) is a selective phosphodiesterase 4 inhibitor administered orally in the treatment o

Palabras claves:

Apremilast, inflammation, Microemulsion, Phosphodiesterase 4, Skin Diseases

Badia J., Calpena A.C., Díaz-Garrido N., Fábrega M.J., Halbaut L., Lupe Carolina Espinoza, Paulo Sarango-Granda, Rodríguez-Lagunas M.J., Silva-Abreu M.

Development of a nasal donepezil-loaded microemulsion for the treatment of Alzheimer’s disease: In vitro and Ex vivo characterization

Abstract: Background: Donepezil (DPZ) is widely prescribed as a specific and reversible acetylcholinesterase i

Palabras claves:

Alzheimer’s disease, Delivery systems, Donepezil, Intranasal route, Microemulsion, permeation

Calpena A.C., Clares-Naveros B., Fábrega M.J., García M.L., Lupe Carolina Espinoza, Vacacela M.

Formulation strategies to improve nose-to-brain delivery of donepezil

Abstract: Donepezil (DPZ) is widely used in the treatment of Alzheimer’s disease in tablet form for oral admin

Palabras claves:

Alzheimer’s disease, Donepezil, Mucoadhesion, NANOEMULSIÓN, Nose-to-brain, Pluronic F-127

Calpena A.C., Cañas M.A., Clares-Naveros B., Halbaut L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Quality by Design of Pranoprofen Loaded Nanostructured Lipid Carriers and Their Ex Vivo Evaluation in Different Mucosae and Ocular Tissues

Abstract: Transmucosal delivery is commonly used to prevent or treat local diseases. Pranoprofen is an anti-in

Palabras claves:

design of experiment, nanostructured lipid carriers, ophthalmic tissues, permeation, porcine mucous membrane

Abrego G., Calpena A.C., Lupe Carolina Espinoza, Mallandrich M., Pesantez-Narvaez J., Rincón M., Silva-Abreu M., Sosa L.

Polyene macrolide antibiotic nanoemulsion: a proposal for the treatment of cutaneous leishmaniasis

Abstract: Leishmaniasis is a neglected tropical disease that requires timely and inexpensive treatment. For th

Palabras claves:

Amphotericin B, Draize test, ex vivo permeation studies, histology, In vitro cytotoxicity, in vitro leishmanicidal activity, leishmaniasis

Díaz M.R., Fuentes J.M., Lupe Carolina Espinoza, Rivas F.R., Siwady J.A., Sosa L.

Nanoemulsion strategy of pioglitazone for the treatment of skin inflammatory diseases

Abstract: Pioglitazone (PGZ)is a peroxisome proliferator-activated receptor agonist. Its role in the inflammat

Palabras claves:

anti-inflammatory activity, cytokines, NANOEMULSIÓN, Pioglitazone, Skin disorders

Calpena A.C., Clares-Naveros B., Fábrega M.J., Garduño-Ramírez M.L., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Thiazolidinedione as an alternative to facilitate oral administration in geriatric patients with Alzheimer's disease

Abstract: Pioglitazone (PGZ) is a member of the thiazolidinedione (TZDs) family of drugs and it is primarily u

Palabras claves:

Alzheimer's disease, Geriatric patients, Mucosal permeation, Oral administration, Pioglitazone, Thiazolidinediones

Calpena A.C., Espina M., García M.L., Gonzalez-Pizarro R., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M.

Topical pioglitazone nanoformulation for the treatment of atopic dermatitis: Design, characterization and efficacy in hairless mouse model

Abstract: Pioglitazone (PGZ) is a drug used to treat type 2 diabetes mellitus that has been reported to show a

Palabras claves:

Atopic dermatitis, NANOEMULSIÓN, Pioglitazone, Pluronic F127

Badia J., Calpena A.C., Clares-Naveros B., Domènech Ò., Lupe Carolina Espinoza, Rodríguez-Lagunas M.J., Silva-Abreu M., Vera-García R.